Treatment of stress urinary incontinence with adipose tissue-derived stem cells
- PMID: 19878076
- PMCID: PMC2871776
- DOI: 10.3109/14653240903350265
Treatment of stress urinary incontinence with adipose tissue-derived stem cells
Abstract
Background aims: Effective treatment for stress urinary incontinence (SUI) is lacking. This study investigated whether transplantation of adipose tissue-derived stem cells (ADSC) can treat SUI in a rat model.
Methods: Rats were induced to develop SUI by postpartum vaginal balloon dilation and bilateral ovariectomy. ADSC were isolated from the peri-ovary fat, examined for stem cell properties, and labeled with thymidine analog BrdU or EdU. Ten rats received urethral injection of saline as a control. Twelve rats received urethral injection of EdU-labeled ADSC and six rats received intravenous injection of BrdU-labeled ADSC through the tail vein. Four weeks later, urinary voiding function was assessed by conscious cystometry. The rats were then killed and their urethras harvested for tracking of ADSC and quantification of elastin, collagen and smooth muscle contents.
Results: Cystometric analysis showed that eight out 10 rats in the control group had abnormal voiding, whereas four of 12 (33.3%) and two of six (33.3%) rats in the urethra-ADSC and tail vein-ADSC groups, respectively, had abnormal voiding. Histologic analysis showed that the ADSC-treated groups had significantly higher elastin content than the control group and, within the ADSC-treated groups, rats with normal voiding pattern also had significantly higher elastin content than rats with voiding dysfunction. ADSC-treated normal-voiding rats had significantly higher smooth muscle content than control or ADSC-treated rats with voiding dysfunction.
Conclusions: Transplantation of ADSC via urethral or intravenous injection is effective in the treatment and/or prevention of SUI in a pre-clinical setting.
Figures





Similar articles
-
Activation of VEGF and ERK1/2 and improvement of urethral function by adipose-derived stem cells in a rat stress urinary incontinence model.Urology. 2012 Oct;80(4):953.e1-8. doi: 10.1016/j.urology.2012.05.030. Epub 2012 Aug 28. Urology. 2012. PMID: 22950999
-
Periurethral injection of autologous adipose-derived stem cells with controlled-release nerve growth factor for the treatment of stress urinary incontinence in a rat model.Eur Urol. 2011 Jan;59(1):155-63. doi: 10.1016/j.eururo.2010.10.038. Epub 2010 Oct 26. Eur Urol. 2011. PMID: 21050657
-
A Functional Comparison of Treatment of Intrinsic Sphincter Deficiency with Muscle-Derived and Adipose Tissue-Derived Stem Cells.IUBMB Life. 2018 Oct;70(10):976-984. doi: 10.1002/iub.1896. Epub 2018 Sep 13. IUBMB Life. 2018. PMID: 30212601
-
Development of cellular therapy for the treatment of stress urinary incontinence.Int Urogynecol J. 2011 Sep;22(9):1075-83. doi: 10.1007/s00192-011-1432-1. Epub 2011 Apr 20. Int Urogynecol J. 2011. PMID: 21505907 Review.
-
Regenerative Medicine-Based Treatment of Stress Urinary Incontinence with Mesenchymal Stem Cells: A Systematic Review and Meta-analysis.Curr Stem Cell Res Ther. 2023;18(3):429-437. doi: 10.2174/1574888X17666220616100621. Curr Stem Cell Res Ther. 2023. PMID: 35713128
Cited by
-
Smooth Muscle Progenitor Cells Derived From Human Pluripotent Stem Cells Induce Histologic Changes in Injured Urethral Sphincter.Stem Cells Transl Med. 2016 Dec;5(12):1719-1729. doi: 10.5966/sctm.2016-0035. Epub 2016 Jul 26. Stem Cells Transl Med. 2016. PMID: 27460854 Free PMC article.
-
Case series of lipid accumulation in the human corpus cavernosum.Medicine (Baltimore). 2015 Feb;94(6):e550. doi: 10.1097/MD.0000000000000550. Medicine (Baltimore). 2015. PMID: 25674764 Free PMC article.
-
The adipose-derived stem cell: looking back and looking ahead.Mol Biol Cell. 2010 Jun 1;21(11):1783-7. doi: 10.1091/mbc.e09-07-0589. Epub 2010 Apr 7. Mol Biol Cell. 2010. PMID: 20375149 Free PMC article.
-
Tissue-engineered sling with adipose-derived stem cells under static mechanical strain.Exp Ther Med. 2017 Aug;14(2):1337-1342. doi: 10.3892/etm.2017.4705. Epub 2017 Jun 28. Exp Ther Med. 2017. PMID: 28810594 Free PMC article.
-
Progress of mesenchymal stem cells affecting extracellular matrix metabolism in the treatment of female stress urinary incontinence.Stem Cell Res Ther. 2025 Feb 25;16(1):95. doi: 10.1186/s13287-025-04220-w. Stem Cell Res Ther. 2025. PMID: 40001265 Free PMC article. Review.
References
-
- Norton P, Brubaker L. Urinary incontinence in women. Lancet. 2006;367:57–67. - PubMed
-
- Hu TW, Wagner TH, Bentkover JD, Leblanc K, Zhou SZ, Hunt T. Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology. 2004;63:461–465. - PubMed
-
- Gibbs CF, Johnson TM, 2nd, Ouslander JG. Office management of geriatric urinary incontinence. Am J Med. 2007;120:211–220. - PubMed
-
- Dooley Y, Kenton K, Cao G, Luke A, Durazo-Arvizu R, Kramer H, et al. Urinary Incontinence Prevalence: Results From the National Health and Nutrition Examination Survey. J Urol. 2007 - PubMed
-
- Albo ME, Richter HE, Brubaker L, Norton P, Kraus SR, Zimmern PE, et al. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. N Engl J Med. 2007;356:2143–2155. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical